Increasing the Impact of Your QI Project with Implementation Science
September 23rd, 2025
Implementation science focuses on how to get effective interventions into practice; however, there is a lack of feasible, pragmatic tools to increase the likelihood that effective treatments get scaled up in healthcare. Workgroups composed of implementation science experts, addiction and pain management intervention developers, and health services researchers from the NIDA-funded Center for Dissemination and Implementation At Stanford (C-DIAS) and HEAL Data2Action Research Adoption Support Center (RASC) developed a set of pragmatic guides and measures to democratize implementation science concepts and frameworks. These guides and measures are designed to support anyone seeking to implement a health care innovation.
Heather Gotham, PhD
Dr. Heather Gotham is a Clinical Associate Professor and clinical psychologist who joined Stanford in August 2018. Her work focuses on increasing the capability of behavioral health and health care providers to implement evidence-based practices that more effectively help people with mental health and substance use disorders. Dr. Gotham directs the SAMHSA-funded National Center for Mental Health Implementation Support, and is Co-Director of the Administrative Core of the HEAL Data2Action Research Adoption Support Center (RASC). She is also a co-PI on an NIH-funded project studying the implementation of substance use disorder screening and treatment approaches in women’s health settings.
Hélène Chokron Garneau, PhD MPH
Dr. Hélène Chokron Garneau is a Senior Research Scientist at the Stanford Center for Dissemination and Implementation (CDI), Stanford University School of Medicine, and serves as Co-Director of the Center for Dissemination & Implementation Science At Stanford (C-DIAS), a National Institute of Drug Abuse (NIDA) Center of Excellence. Her work focuses on bridging the research to practice gap for evidence based practices in the fields of addiction, mental health services, and primary care, with the ultimate goal of making evidenced based practices accessible to all. Prior to joining Stanford School of Medicine in 2019, Dr. Chokron Garneau worked at the UCLA Integrated Substance Abuse Programs (ISAP) where she assisted in the development, implementation, and evaluation of behavioral interventions for substance users with comorbid psychiatric diagnoses.
